Have a personal or library account? Click to login
An overlap syndrome of myasthenia gravis, myocarditis, myositis and hepatitis triggered by immune checkpoint inhibitor use Cover

An overlap syndrome of myasthenia gravis, myocarditis, myositis and hepatitis triggered by immune checkpoint inhibitor use

Forum of Clinical Oncology
AHEAD OF PRINT
By: Philip Macilwraith,  Darren Ngo,  Hossein Zareie,  Zi-Hao Tan and  Chun Loo Gan  
Open Access
|May 2025

Authors

Philip Macilwraith

112302221@umail.ucc.ie

Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia

Darren Ngo

Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia

Hossein Zareie

Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia

Zi-Hao Tan

Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia

Chun Loo Gan

Royal Brisbane and Woman’s Hospital Health Service District: Royal Brisbane and Women’s Hospital, Brisbane, Australia
DOI: https://doi.org/10.2478/fco-2024-0004 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Submitted on: Aug 1, 2024
Accepted on: Nov 24, 2024
Published on: May 18, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Myasthenia gravis,
immune checkpoint inhibitors,
myocarditis,
immune-related adverse effects,
metastatic melanoma
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2025 Philip Macilwraith, Darren Ngo, Hossein Zareie, Zi-Hao Tan, Chun Loo Gan, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT